Notwithstanding, the intricate interplay among FGF23, parathyroid hormone, and 1α,25-dihydroxy-vitamin D holds significance in the context of a pathological condition known as mineral and bone disorder, which occurs in individuals with chronic kidney disease (CKD-MBD). Here, FGF23 is linked to chronic kidney disease.